Cellectis sells Swedish subsidiary Cellectis AB to Takara Bio
Client(s) Cellectis SA
Jones Day advised Cellectis, a leader in the development of adoptive immunotherapies based on engineered allogeneic CART cells (UCART), in the sale of its subsidiary Cellectis AB to Takara Bio Inc.